ARTV
Artiva Biotherapeutics, Inc.
7.00$
-6.7%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | – | – | – | – | – | |
| – | +239.7% | +366.9% | +95.7% | +7.3% | +6.8% | |
| – | +1,350.2% | +52.9% | +7.1% | -1.0% | -2.3% | |
| – | +666.7% | -111.6% | – | – | – | |
| – | +507.0% | +265.4% | -48.3% | -80.3% | +303.0% | |
| – | +507.0% | +265.4% | +312.4% | +363.8% | – | |
| – | – | – | +140.0% | +34,758.3% | -100.0% | |
| – | – | – | – | – | -11.4% | |
| – | +308.5% | -100.8% | – | +565.1% | -100.0% | |
| – | +475.8% | -143.0% | – | – | – | |
| – | – | – | – | – | – |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.